@apexalphatrading: 30/09: Citi has cut Moderna to Sell with an $80 target.. roughly 60% below Tuesday's close. The stock is up over 200% since the August melanoma data and looks very overbought. There is still so much to prove before it justifies an $80 billion market cap. Daily market analysis built the way institutions do it. Join Apex, and read Tech World, my weekly written note.. link in bio #mrna #moderna #investing #cancer #stocks